Skip to content Skip to sidebar Skip to footer

User-friendly features of Decentralized Clinical Trials (DCTs)

Decentralized Clinical Trials (DCTs) represent a shift in paradigm in the clinical study landscape, suggesting a host of features that are user-friendly and heighten the experience for both participants and researchers overall. Adopting the influence of technology, DCTs influence digital platforms, capabilities that are remote, and tools that are innovative to make more convenient and…

Read More

Self-monitoring in Decentralized Clinical Trials (DCTs): Key Components & Benefits

Decentralized trials (DCTs) lay emphasis on remote data access for various tasks and functions.  Self-monitoring by patients is one of such tasks and in DCTs refers to the practice of trial subjects completing their health records remotely and actively participating in the progress of a clinical trial from their own homes or other non-traditional settings.…

Read More

How Decentralized Clinical Trials (DCTs) Empower Investigators: Key Benefits and Insights

Decentralized clinical trials (DCTs) are a modern approach to conducting clinical research that aims to enhance efficiency, accessibility, and participant engagement. These trials leverage technology to collect data remotely, reducing the need for participants to visit traditional clinical trial sites. In DCTs, investigators are at the center of the activities and play a crucial role…

Read More

Digital Technologies for Healthcare Management

In recent years, the integration of digital technologies into healthcare has revolutionized the way patients manage their health and well-being. These technologies have empowered patients to actively participate in their healthcare journey, providing tools and resources that enable them to monitor their health, access medical information, and communicate with healthcare providers more effectively. From health…

Read More

Drug Approval Process in South Africa

In the past 50 years, South Africa has established a regulating body for medicines that is acknowledged internationally. According to the Medicines Control Council (MCC), it is "the national medicines regulatory authority of South Africa, which is responsible, in accordance with the medicines and related substances act, 1965 (Act 101 of 1965), for providing for…

Read More

Understanding the Financial Ecosystem Surrounding the Development of Medicines

Developing medicines is a long intricate process that involves several players and stakeholders. It requires a huge number of financial resources coupled with infrastructure and skilled manpower. The entire agglomeration of these several players is interconnected and dependent on each other for financing every incremental step of innovation and development. This creates an interconnected ecosystem.…

Read More

Request a Quote

Fill out the form below, and we will be in touch shortly.